Amgen Inc. (AMGN) Q4 2014 Earnings Results

Amgen Beats on EPS, Stock Down 0.5%

Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.5%, which may reflect investor caution due to the lack of revenue data and forward guidance. The company's focus on shareholder value suggests a commitment to maintaining performance, but uncertainty remains.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.16	N/A	+5.62%

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the earnings per share results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for the upcoming quarters.

We are pleased with our EPS performance this quarter.

Our focus remains on delivering value to our shareholders.

Amgen Beats on EPS, Stock Down 0.5%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 0.5%

Key numbers

Management commentary